Request Demo
Last update 15 Oct 2026
NW-301V
Last update 15 Oct 2026
Overview
Basic Info
Drug Type TCR-T Cell therapy |
Synonyms TCR-T T cell targeting KRAS G12V mutation, NW-301V |
Target |
Action modulators |
Mechanism KRAS G12V modulators(GTPase KRas G12V modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with NW-301VNCT07875920
A Single-Arm, Multicenter, Open-Label, Phase Ia/Ib Clinical Study of NW-301V in Advanced Solid Tumors Harboring KRAS G12V Mutations
NCT07474168
An Open-Label, Dose-Escalation Phase I Clinical Study of T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
NCT06478251
An Open-Label, Dose-Escalation Phase I Clinical Study of T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
100 Clinical Results associated with NW-301V
Login to view more data
100 Translational Medicine associated with NW-301V
Login to view more data
100 Patents (Medical) associated with NW-301V
Login to view more data
100 Deals associated with NW-301V
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Adenocarcinoma of large intestine | Phase 1 | China | 01 Oct 2026 | |
| Adenocarcinoma of Lung | Phase 1 | China | 01 Oct 2026 | |
| Pancreatic Ductal Adenocarcinoma | Phase 1 | China | 01 Oct 2026 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 10 May 2025 | |
| KRAS mutation-related tumors | IND Approval | China | 16 Sep 2026 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free